PubMed Clinical Queries for "BRCA"

PubMed Clinical Queries





From PubMed Clinical Queries

PubMed Clinical Queries is an utility offered by PubMed to search scientific literature in specific clinical research areas

---

• Search PubMed Clinical Queries for "Brca" 

Results: 5 of 859

• Latest clinical evidence and further development of PARP inhibitors in ovarian cancer.
  Mirza MR, Pignata S, Ledermann JA.Ann Oncol. 2018 May 10; . Epub 2018 May 10.
• Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months.
  Rizzo S, Botta F, Raimondi S, Origgi D, Buscarino V, Colarieti A, Tomao F, Aletti G, Zanagnolo V, Del Grande M, et al.Eur Radiol. 2018 May 8; . Epub 2018 May 8.
• Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
  Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KH.Gynecol Oncol. 2018 May 4; . Epub 2018 May 4.
• Sistas Inspiring Sistas Through Activity and Support (SISTAS): Study Design and Demographics of Participants.
  Bevel M, Babatunde OA, Heiney SP, Brandt HM, Wirth MD, Hurley TG, Khan S, Johnson H, Wineglass CM, Warren TY, et al.Ethn Dis. 2018 Spring; 28(2):75-84. Epub 2018 Apr 26.
• Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review.
  Sæther NH, Skuja E, Irmejs A, Maksimenko J, Miklasevics E, Purkalne G, Gardovskis J.Hered Cancer Clin Pract. 2018; 16:9. Epub 2018 Apr 27.

See all (859)

This column displays citations filtered to a specific clinical study category and scope. These search filters were developed by Haynes RB et al. See more filter information.

Systematic Reviews

Results: 5 of 142

• How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies.
  Park JH, Ahn JH, Kim SB.ESMO Open. 2018; 3(Suppl 1):e000357. Epub 2018 May 3.
• Outcome and Prognostic Impact of Surgical Staging in Serous Tubal Intraepithelial Carcinoma: A Cohort Study and Systematic Review.
  Van der Hoeven NMA, Van Wijk K, Bonfrer SE, Beltman JJ, Louwe LA, De Kroon CD, Van Asperen CJ, Gaarenstroom KN.Clin Oncol (R Coll Radiol). 2018 Apr 21; . Epub 2018 Apr 21.
• The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer.
  Reinert T, Nogueira-Rodrigues A, Kestelman FP, Ashton-Prolla P, Graudenz MS, Bines J.Clin Breast Cancer. 2018 Mar 12; . Epub 2018 Mar 12.
• Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.
  Ring KL, Modesitt SC.Obstet Gynecol Clin North Am. 2018 Mar; 45(1):155-173.
• Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.
  Petelin L, Trainer AH, Mitchell G, Liew D, James PA.Genet Med. 2018 Jan 11; . Epub 2018 Jan 11.

See all (142)

This column displays citations for systematic reviews, meta-analyses, reviews of clinical trials, evidence-based medicine, consensus development conferences, and guidelines. See filter information or additional related sources.

Medical Genetics

Topic:AllDiagnosisDifferential DiagnosisClinical DescriptionManagementGenetic CounselingMolecular GeneticsGenetic Testing

Results: 5 of 2898

• Physician liability: the next big thing for personalized medicine?
  Marchant GE, Campos-Outcalt DE, Lindor RA.Per Med. 2011 Jul; 8(4):457-467.
• Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
  Kotsopoulos J, Gronwald J, Lynch HT, Eisen A, Neuhausen SL, Tung N, Ainsworth P, Weitzel JN, Pal T, Foulkes WD, et al.Breast Cancer Res Treat. 2018 May 17; . Epub 2018 May 17.
• Frequency of Rearrangements Versus Small Indels Mutations in <i>BRCA1</i> and <i>BRCA2</i> Genes in Turkish Patients with High Risk Breast and Ovarian Cancer.
  Yazıcı H, Kılıç S, Akdeniz D, Şükrüoğlu Ö, Tuncer ŞB, Avşar M, Kuru G, Çelik B, Küçücük S, Saip P.Eur J Breast Health. 2018 Apr; 14(2):93-99. Epub 2018 Apr 1.
• Inadequate Rates of BRCA Testing with its Negative Consequences for Women with Epithelial Ovarian Cancer and their Families: an Overview of the Literature.
  Hoskins PJ.Clin Oncol (R Coll Radiol). 2018 May 5; . Epub 2018 May 5.
• Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
  Elsayegh N, Webster RD, Gutierrez Barrera AM, Lin H, Kuerer HM, Litton JK, Bedrosian I, Arun BK.Cancer Med. 2018 May 7; . Epub 2018 May 7.

See all (2898)

This column displays citations pertaining to topics in medical genetics. See more filter information.